fifty-two percent of patients had hepatocellular carcinomas ( hcc ) , 24 % cholangiocarcinomas , 10 % other primary liver tumors , and 14 % metastatic hepatic tumors .
C2239176
hepatocellular carcinomas
C0023884
liver